Concord Healthcare Group Co., Ltd. (HKG:2453)

Market Cap	705.30M -84.5%
Revenue (ttm)	511.81M +18.4%
Net Income	-285.55M
EPS	-0.38
Shares Out	783.66M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	164,800
Open	0.8800
Previous Close	0.8800
Day's Range	0.8500 - 0.9400
52-Week Range	0.8000 - 7.9100
Beta	-0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 11, 2026

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company offers oncology-related services, including sale and installation of medical equipment and software; and management and technical support services to hospitals and radiotherapy centers. It also engages in leasing radiotherapy and diagnostic imaging equipment; trading of r...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 592
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2453

Financial Performance

In 2025, Concord Healthcare Group's revenue was 459.92 million, an increase of 18.44% compared to the previous year's 388.31 million. Losses were -256.60 million, -42.11% less than in 2024.

Financial numbers in CNY